Menu Menu

KNSA    Kiniksa Pharmaceuticals International Plc    1730430    
Income Statement
Revenue knsa-20241231x10k 423,239,000
Net Income knsa-20241231x10k -43,193,000
Profit Margin -10.21%

Balance Sheet
Current Assets 331,799,000
Assets 580,553,000
Current Liabilities 100,621,000
Liabilities 142,117,000
Equity 438,436,000
Shares Out 45,901,000

Cash Flow Statement
Operating Cash Flow 25,689,000
Investing Cash Flow 37,672,000

Market Analysis
Market Cap 3,307,770,406
Price 43.04
BVPS 10.80
PB 2.13
EPS 0.75
PE 57.61
PS 1.06
FCF 63,361,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
2/25 -0.60
Apr May Jun
4/23 -0.25
Jul Aug Sep
7/23 -0.06
Oct Nov Dec
10/29

Find a discrepancy? The most accurate way to find company fundamental data is to view KNSA documents filed with the SEC.


KNSA Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker:



View A List of Tickers





We can also help with your taxes.

Formal Tax

www.formal.tax





(402) 804-8293


Formal Financial App
Google Play - Apple Store

created using: Admin Canvas